Beauty experts and Ozempic face fears
Beauty experts are exploiting the concerns of users of obesity treatment medications, especially Ozempic, who suffer from sagging and loss of facial volume due to rapid weight loss associated with these drugs. Companies such as Galderma, L'Oréal, and Natura are moving towards developing cosmetic treatments targeting facial changes caused by volume loss, particularly sagging and skin drooping, through the use of products like collagen injections and dermal fillers. While some skincare creams may help improve skin appearance, they cannot restore lost volume or alter the structure of deep tissues. The market is increasingly leaning towards more effective treatments like fillers and injections that reach the internal tissues. This comes amidst predictions that the obesity drug market could reach $150 billion by 2030, with the associated cosmetic treatments growing rapidly.
Notice: This Is an AI-Generated Summary
Comments (0)